| Price and Volume | |
|---|---|
| Recent Price | 10.05 |
| 52 Week High | 12.44 |
| 52 Week Low | 4.55 |
| Avg. Daily Vol. (Mil) | 0.31 |
| Beta (3 year) | 1.59 |
| Share Related Items | |
| Mkt Cap (Mil) | 276.42 |
| Shares Out (Mil) | 27.50 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 8.00 |
| Current Ratio | 8.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | N.A. |
| Price/Sales | 5.07 |
| Price/Book | 1.21 |
| Price/Cash Flow | -8.40 |
| Per Share Data | |
| Earnings | -1.28 |
| Sales | 1.98 |
| Book Value | 8.29 |
| Cash Flow | -1.19 |
| Business Summary | |
|---|---|
| The Company designs, develops and markets aesthetic medical products based on its proprietary ELOS technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments. | |
| General Information | |
| Industrial Zone,Taylor Bldg
P.O. Box 550 Yokeneam Illit, 20692 |
|
| 0.99999999999794 | |
| www.syneron.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 274 | |
| CEO: Louis Scafuri | |
| Short Interest | |
| Current Month (Mil) | 2.33 |
| Previous Month (Mil) | 2.08 |
| Short Interest Ratio (Days) | 11.00 |
| Management Effectiveness | |
| Return on Equity | N.A. |
| Return on Assets | -13.60 |
| Return on Investments | -15.00 |
| Profitability | |
| Gross Margin | 65.70 |
| EBIT Margin | -58.20 |
| Profit Margin | -64.40 |